Overview
Olivia Kates is an Infectious Disease provider in Baltimore, Maryland. Dr. Kates is rated as an Experienced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. Her top areas of expertise are COVID-19, Diphtheria, Severe Acute Respiratory Syndrome (SARS), and Listeriosis.
Her clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Respiratory Syncytial Virus (RSV) Infection.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1717 East Monument Street, Park Building, Ground Level, Park Building, Ground Level, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Nate Permpalung is an Associate Professor of Medicine and serves as the Director of Mycology Research in the Division of Infectious Diseases and Associate Director for Clinical Trials of Transplant Research Center at Johns Hopkins University School of Medicine. In his capacity as a Transplant Infectious Disease physician at Johns Hopkins Hospital, he provides specialized care to immunocompromised patients, including those who have undergone solid organ transplants and those undergoing cancer treatment. His research focuses are respiratory viral infections, invasive fungal infections, fungal-viral interactions, fungal diagnostics, and human pythiosis. Nationally, Dr. Permpalung has served on the panel for the IDSA Aspergillosis Guidelines development and has held editorial positions as Associate Editor for Medical Mycology and as an Editorial Board Member for the Journal of Heart and Lung Transplantation Open. Dr. Permpalung is rated as an Experienced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are Febrile Neutropenia, Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, and COVID-19.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.
Antonio Pastor is an Infectious Disease provider in Sterling, Virginia. Dr. Pastor is rated as an Advanced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Hospital-Acquired Pneumonia, and Lymphangitis. Dr. Pastor is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Kates isAdvanced. Learn about COVID-19.
- DiphtheriaDr. Kates isAdvanced. Learn about Diphtheria.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Cytomegalic Inclusion DiseaseDr. Kates isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionDr. Kates isExperienced. Learn about Cytomegalovirus Infection.
- Disseminated TuberculosisDr. Kates isExperienced. Learn about Disseminated Tuberculosis.
- Kaposi SarcomaDr. Kates isExperienced. Learn about Kaposi Sarcoma.
- ListeriosisDr. Kates isExperienced. Learn about Listeriosis.
- NocardiosisDr. Kates isExperienced. Learn about Nocardiosis.